Skip to content

HIV and TB in Practice for nurses: non-communicable diseases, HIV and TB

South Africa exceeds 2007-11 treatment targets by 50%

US regulators set to approve HIV home-testing kit

Standard hepatitis C therapy improves insulin resistance in HIV/hepatitis C co-infected patients

BI 201335 & BI 207127 and ribavirin shows good efficacy, including hepatitis C patients with cirrhosis

Strengthening TB laboratory capacity to support active case finding

US regulators vote for approval of PrEP by large majority

Canadian cohort shows viral suppression most likely with atazanavir/ritonavir-based HIV treatment after 6 months

Ribavirin dose reduction is effective for managing anaemia in patients using boceprevir or telaprevir